Form 8-K - Current report:
SEC Accession No. 0001493152-25-007573
Filing Date
2025-02-19
Accepted
2025-02-19 16:15:12
Documents
14
Period of Report
2025-02-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44501
  Complete submission text file 0001493152-25-007573.txt   267100

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20250212.xsd EX-101.SCH 3883
3 XBRL DEFINITION FILE cdt-20250212_def.xml EX-101.DEF 26778
4 XBRL LABEL FILE cdt-20250212_lab.xml EX-101.LAB 37007
5 XBRL PRESENTATION FILE cdt-20250212_pre.xml EX-101.PRE 25402
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6154
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25640197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)